Citations (166)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (26)
Benjamin H. Garland, Robert M. Mindrup, Lisa K. Zottarelli & Jill D. McCarley. (2023) Effects of a same-day post-detoxification residential alcohol use disorder treatment admission policy. Journal of Social Work Practice in the Addictions 23:2, pages 65-75.
Read now
Read now
Joanne Neale, Stephen Parkin & John Strang. (2023) Qualitative study of patients’ decisions to initiate injectable depot buprenorphine for opioid use disorder: the role of information and other factors. Drugs: Education, Prevention and Policy 0:0, pages 1-11.
Read now
Read now
Cayley Russell, Michelle Pang, Frishta Nafeh, Shanna Farrell Macdonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada. International Journal of Qualitative Studies on Health and Well-being 17:1.
Read now
Read now
Christina Mutschler, Heather Haines, Charlie Gryspeerdt, Julianne Bushe, Kelly McShane, Michael Lochran & Laura Bhoi. (2022) Integration of Twelve Step with Evidence-Based Practices in a Residential Treatment Center. Substance Use & Misuse 57:14, pages 2110-2116.
Read now
Read now
Nico Carswell, Giselle Angermaier, Christopher Castaneda & Fabrizzio Delgado. (2022) Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Hospital Practice 50:4, pages 251-258.
Read now
Read now
Alicia L. Nobles, Derek C. Johnson, Eric C. Leas, David Goodman-Meza, María Luisa Zúñiga, Douglas Ziedonis, Steffanie A. Strathdee & John W. Ayers. (2021) Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19. Substance Use & Misuse 56:14, pages 2134-2140.
Read now
Read now
Lauren E. Hood, Jonna M. Leyrer-Jackson & M. Foster Olive. (2020) Pharmacotherapeutic management of co-morbid alcohol and opioid use. Expert Opinion on Pharmacotherapy 21:7, pages 823-839.
Read now
Read now
Madison K. Bangert & Gabriel M. Aisenberg. (2020) Drug deprescription—withdrawal risk, prevention, and treatment. Baylor University Medical Center Proceedings 33:2, pages 213-217.
Read now
Read now
Zahra Mohtashami, Zahra Esmaili, Molood Alsadat Vakilinezhad, Ehsan Seyedjafari & Hamid Akbari Javar. (2020) Pharmaceutical implants: classification, limitations and therapeutic applications. Pharmaceutical Development and Technology 25:1, pages 116-132.
Read now
Read now
Saul Alcaraz, Carme Viladrich, Joan Trujols, Núria Siñol & José Pérez de los Cobos. (2018) Heroin-dependent patient satisfaction with methadone as a medication influences satisfaction with basic interventions delivered by staff to implement methadone maintenance treatment. Patient Preference and Adherence 12, pages 1203-1211.
Read now
Read now
Alan K. Davis, Elise Renn, Austin-Marley Windham-Herman, Martin Polanco & Joseph P. Barsuglia. (2018) A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification. Journal of Psychoactive Drugs 50:4, pages 287-297.
Read now
Read now
Sunil Sirohi & Amit K Tiwari. (2016) Pain in the management of opioid use disorder. Journal of Pain Research 9, pages 963-966.
Read now
Read now
Marco Pravetoni. (2016) Biologics to treat substance use disorders: Current status and new directions. Human Vaccines & Immunotherapeutics 12:12, pages 3005-3019.
Read now
Read now
Cory A. Crane, Robert C. Schlauch, Susan Devine & Caroline J. Easton. (2016) Comorbid substance use diagnoses and partner violence among offenders receiving pharmacotherapy for opioid dependence. Journal of Addictive Diseases 35:3, pages 205-211.
Read now
Read now
Stephanie Lake & Mary Clare Kennedy. (2016) Health outcomes associated with illicit prescription opioid injection:A systematic review. Journal of Addictive Diseases 35:2, pages 73-91.
Read now
Read now
Jordan B. King, Amy M. Sainski-Nguyen & Brandon K. Bellows. (2016) Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis. Journal of Pain & Palliative Care Pharmacotherapy 30:1, pages 55-65.
Read now
Read now
Christine Timko, Nicole R. Schultz, Michael A. Cucciare, Lisa Vittorio & Christina Garrison-Diehn. (2016) Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases 35:1, pages 22-35.
Read now
Read now
Farzaneh Tabassomi, Mehran Zarghami, Mohammad-Reza Shiran, Samaneh Farnia & Mohsen Davoodi. (2016) Opium tincture versus methadone syrup in management of acute raw opium withdrawal: A randomized, double-blind, controlled trial. Journal of Addictive Diseases 35:1, pages 8-14.
Read now
Read now
Camila Gelpi-Acosta. (2015) Challenging biopower: “Liquid cuffs” and the “Junkie” habitus. Drugs: Education, Prevention and Policy 22:3, pages 248-254.
Read now
Read now
Sarah K. Moore, Honoria Guarino & Lisa A. Marsch. (2014) “This is Not Who I Want to be:” Experiences of Opioid-Dependent Youth Before, and During, Combined Buprenorphine and Behavioral Treatment. Substance Use & Misuse 49:3, pages 303-314.
Read now
Read now
Thomas R Kosten & Coreen B Domingo. (2013)
Can you vaccinate against substance abuse?
. Expert Opinion on Biological Therapy 13:8, pages 1093-1097.
Read now
Read now
Maciej L. Goniewicz & Marcin Delijewski. (2013) Nicotine vaccines to treat tobacco dependence. Human Vaccines & Immunotherapeutics 9:1, pages 13-25.
Read now
Read now
Brian Johnson & Stephen V. Faraone. (2013) Outpatient Detoxification Completion and One-Month Outcomes for Opioid Dependence: A Preliminary Study of a Neuropsychoanalytic Treatment in Pain Patients and Addicted Patients. Neuropsychoanalysis 15:2, pages 145-160.
Read now
Read now
Mehran Zarghami, Babak Masoum & Mohammad-Reza Shiran. (2012) Tramadol versus Methadone for Treatment of Opiate Withdrawal: A Double-Blind, Randomized, Clinical Trial. Journal of Addictive Diseases 31:2, pages 112-117.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Marta Rodríguez-Arias, María Asunción Aguilar, Carmen Manzanedo & José Miñarro. (2010) Preclinical evidence of new opioid modulators for the treatment of addiction. Expert Opinion on Investigational Drugs 19:8, pages 977-994.
Read now
Read now
Articles from other publishers (140)
Mary B. Kleinman, Abigail C. Hines, Morgan S. Anvari, Valerie D. Bradley, Alia Shields, Dwayne Dean, Tolulope M. Abidogun, Helen E. Jack & Jessica F. Magidson. (2023) “You rise up and then you start pulling people up with you”: Patient experiences with a peer-delivered behavioral activation intervention to support methadone treatment. International Journal of Drug Policy 122, pages 104234.
Crossref
Crossref
Tabitha E. H. Moses, Eva Waineo, Diane Levine & Mark K. Greenwald. (2023) Optimizing buprenorphine training during undergraduate medical education: Medical student feedback and attitudes. The American Journal on Addictions 32:4, pages 376-384.
Crossref
Crossref
Alexandros Psarianos, Costas Chryssanthopoulos, Thomas Paparrigopoulos & Anastassios Philippou. (2023) The Role of Physical Exercise in Opioid Substitution Therapy: Mechanisms of Sequential Effects. International Journal of Molecular Sciences 24:5, pages 4763.
Crossref
Crossref
Samaneh Omranian, Maryam Zolnoori, Ming Huang, Celeste Campos-Castillo & Susan McRoy. (2023) Predicting Patient Satisfaction With Medications for Treating Opioid Use Disorder: Case Study Applying Natural Language Processing to Reviews of Methadone and Buprenorphine/Naloxone on Health-Related Social Media. JMIR Infodemiology 3, pages e37207.
Crossref
Crossref
Yen-Feng Lin, Wen-Hai Chou, Tung-Hsia Liu, Chiu-Ping Fang, Hsiang-Wei Kuo, Po-Hsiu Kuo, Shih-Jen Tsai, Sheng-Chang Wang, Ren-Hua Chung, Hsiao-Hui Tsou, Andrew C. H. Chen & Yu-Li Liu. (2022) Splice-Site Variants in the Gene Encoding GABA-A Receptor Delta Subunit Are Associated with Amphetamine Use in Patients under Methadone Maintenance Treatment. International Journal of Molecular Sciences 24:1, pages 721.
Crossref
Crossref
Cayley Russell, Frishta Nafeh, Michelle Pang, Shanna Farrell MacDonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study. BMC Public Health 22:1.
Crossref
Crossref
Piyusha P. Pagare, Samuel Obeng, Boshi Huang, Madison M. Marcus, Katherine L. Nicholson, Andrew E. Townsend, Matthew L. Banks & Yan Zhang. (2022) Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment. ACS Pharmacology & Translational Science 5:11, pages 1197-1209.
Crossref
Crossref
Vierne Placide, Lynn Unruh, Danielle Atkins, Latarsha Chisholm & J. Blake Scott. (2022) Factors associated with counselling adherence in opioid treatment programs. Health & Social Care in the Community 30:6.
Crossref
Crossref
Sobhan Kasraeifar, Amin Mokhtari-Zaer, Narges Marefati, Hassan Rakhshandeh & Mahmoud Hosseini. (2022) Suppressive Effects of the Aerial Parts of Datura Stramonium L. Extract on Naloxone-Precipitated Morphine Withdrawal Signs in Mice. Journal of Advances in Medical and Biomedical Research 30:143, pages 561-565.
Crossref
Crossref
Jessica F. Magidson, Mary B. Kleinman, Valerie Bradley, Morgan S. Anvari, Tolulope M. Abidogun, Annabelle M. Belcher, Aaron D. Greenblatt, Dwayne Dean, Abigail Hines, C.J. Seitz-Brown, Michael Wagner, Melanie Bennett & Julia W. Felton. (2022) Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial. International Journal of Drug Policy 108, pages 103813.
Crossref
Crossref
Megan R. Greener & Sarah J. Storr. (2022) Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them. NeuroSci 3:3, pages 494-509.
Crossref
Crossref
Cayley Russell, Shannon Lange, Fiona Kouyoumdjian, Amanda Butler & Farihah Ali. (2022) Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?. Harm Reduction Journal 19:1.
Crossref
Crossref
Treah Haggerty, Maryam Khodaverdi, Patricia Dekeseredy, Nathan Wood, Brian Hendricks, Jason Peklinsky & Cara L. Sedney. (2022) Assessing the impact of social distancing measures implemented during COVID-19 pandemic on medications for opioid use disorder in West Virginia. Journal of Substance Abuse Treatment 136, pages 108687.
Crossref
Crossref
Piyusha P. Pagare, Mengchu Li, Yi Zheng, Abhishek S. Kulkarni, Samuel Obeng, Boshi Huang, Christian Ruiz, James C. Gillespie, Rolando E. Mendez, David L. Stevens, Justin L. Poklis, Matthew S. Halquist, William L. Dewey, Dana E. Selley & Yan Zhang. (2022) Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. Journal of Medicinal Chemistry 65:6, pages 5095-5112.
Crossref
Crossref
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian & Zurina Hassan. (2022) Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy. Neuroscience Letters 773, pages 136500.
Crossref
Crossref
Martin Hochheimer & George Jay Unick. (2022) Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States. Addictive Behaviors 124, pages 107113.
Crossref
Crossref
Chrianna Bharat, Sarah Larney, Sebastiano Barbieri, Timothy Dobbins, Nicola R. Jones, Matthew Hickman, Natasa Gisev, Robert Ali & Louisa Degenhardt. (2021) The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study. Addiction 116:11, pages 3139-3152.
Crossref
Crossref
Valerie S. Harder, Andrea C. Villanti, Sarah H. Heil, M. Lindsey Smith, Diann E. Gaalema, Marjorie C. Meyer, Nathaniel H. Schafrick & Stacey C. Sigmon. (2021) Opioid use disorder treatment in rural settings: The primary care perspective. Preventive Medicine 152, pages 106765.
Crossref
Crossref
Warren R. Korn, Matthew D. Stone, Kaddie L. Haviland, Joanne M. Toohey & Douglas F. Stickle. (2021) High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021. Clinica Chimica Acta 521, pages 151-154.
Crossref
Crossref
Marcelo Ribeiro, Rosana Frajzinger, Luciane Ogata Perrenoud & Benedikt Fischer. (2021) Examining a migration-based phenomenon of heroin use in an urban drug scene in Sao Paulo, Brazil. International Journal of Migration, Health and Social Care 17:3, pages 274-285.
Crossref
Crossref
Lucja Kudla & Ryszard Przewlocki. (2021) Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors. Pharmacological Reports 73:4, pages 1033-1051.
Crossref
Crossref
David A Fishbain. (2021) Opioid Tapering/Detoxification Protocols, A Compendium: Narrative Review. Pain Medicine 22:7, pages 1676-1697.
Crossref
Crossref
Christian A. Tomaszewski, Faith Quenzer, Bryan Corbett, Andrew Lafree, Daniel Lasoff, Jorge Romo & Leslie Mukau. (2021) Interobserver agreement between emergency clinicians and nurses for Clinical Opiate Withdrawal Scale. Journal of the American College of Emergency Physicians Open 2:3.
Crossref
Crossref
Jermaine D. Jones, Neil B. Varshneya, Thomas J. Hudzik & Andrew S. Huhn. (2021) Improving Translational Research Outcomes for Opioid Use Disorder Treatments. Current Addiction Reports 8:1, pages 109-121.
Crossref
Crossref
Annie Talbot, Rania Khemiri, Aïssata Sako, Luc Londei-Leduc, Christine Robin, Suzanne Marcotte, Guenièvre Therrien, Geneviève Goulet, Geneviève Beaudet Hillman, Christine Ouellette, Suzanne Brissette, Marcel Martin, Polina Titova & Pierre Lauzon. (2021) Déploiement d’un algorithme de soins en réponse à la crise des opioïdesAn algorithm of care as a response to the opioid crisisImplementación de un algoritmo de asistencia en respuesta a la crisis de los opioides. Drogues, santé et société 19:1-2, pages 178.
Crossref
Crossref
Wafae Idrissi Semlali, Tarik Ghailan, Khadija Karjouh & Ahmed Omar Touhami Ahami. 2021. Advances in Human Factors and Ergonomics in Healthcare and Medical Devices. Advances in Human Factors and Ergonomics in Healthcare and Medical Devices
122
130
.
Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane & Zainab Samaan. (2020) GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol. Systematic Reviews 9:1.
Crossref
Crossref
Reda M. Chalhoub & Peter W. Kalivas. (2020) Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs 80:15, pages 1509-1524.
Crossref
Crossref
Robert RIch, Roger Chou, Edward R. Mariano, Anna Legreid Dopp, Rebecca Sullenger & Helen Burstin. (2020) Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings. NAM Perspectives.
Crossref
Crossref
Brian Maila, Anatolii Tsarkov, Petro Petlovanyi, Gaise Kweku & Evans Musonda. (2020) Treatment of Opioid Use Disorder With Buprenorphine-Naloxone at Chainama Hills College Hospital in Lusaka, Zambia: A Case Report. European Journal of Medical and Health Sciences 2:4.
Crossref
Crossref
Kaushal Shah, Billy Stout & Hunter Caskey. (2020) Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials. Cureus.
Crossref
Crossref
Ewa Galaj, Amy Hauck Newman & Zheng-Xiong Xi. (2020) Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges. Neuroscience & Biobehavioral Reviews 114, pages 38-52.
Crossref
Crossref
Chiu-Ping Fang, Tung-Hsia Liu, Ren-Hua Chung, Hsiao-Hui Tsou, Hsiang-Wei Kuo, Sheng-Chang Wang, Chia-Chen Liu, Shu Chih Liu, Andrew C. H. Chen & Yu-Li Liu. (2020) Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use. PLOS ONE 15:6, pages e0234549.
Crossref
Crossref
Graham Blair, Corinne Wells, Ashley Ko, John Modarres, Caroline Pace, James M. Davis, Amir H. Rezvani, Jed E. Rose & Edward D. Levin. (2020) Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats. Pharmacology Biochemistry and Behavior 193, pages 172919.
Crossref
Crossref
Javier A Cepeda, Annick Bórquez, Christopher Magana, Anh Vo, Claudia Rafful, Gudelia Rangel, María E Medina‐Mora, Steffanie Strathdee & Natasha K Martin. (2020) Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico. Journal of the International AIDS Society 23:S1.
Crossref
Crossref
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, Joe Barry & Fiona Boland. (2020) Retention of patients in opioid substitution treatment: A systematic review. PLOS ONE 15:5, pages e0232086.
Crossref
Crossref
Tyler S. Oesterle, Bhanu Prakash Kolla, Teresa A. Rummans & Mark S. Gold. (2020) Medication-assisted therapies for opioid use disorders in patients with chronic pain. Journal of the Neurological Sciences 411, pages 116728.
Crossref
Crossref
Bahareh Ebrahimi & Saeed Esmaeili-Mahani. (2020) The Effects of Hydroalcoholic Extract of Satureja khuzestanica on Naloxone-Induced Morphine Withdrawal Symptoms in Wistar Rats. International Journal of Basic Science in Medicine 5:1, pages 16-21.
Crossref
Crossref
Qiaoyan Li, Siqi Chen, Ke Liu, Danfeng Long, Diru Liu, Zhengchao Jing & Xiaodan Huang. (2020) Differences in Gut Microbial Diversity are Driven by Drug Use and Drug Cessation by Either Compulsory Detention or Methadone Maintenance Treatment. Microorganisms 8:3, pages 411.
Crossref
Crossref
Hannu Alho, Maurice Dematteis, Danilo Lembo, Icro Maremmani, Carlos Roncero & Lorenzo Somaini. (2020) Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern. International Journal of Drug Policy 76, pages 102616.
Crossref
Crossref
F. Homayra, N. Hongdilokkul, M. Piske, L.A. Pearce, H. Zhou, J.E. Min, E. Krebs & B. Nosyk. (2020) Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia. Drug and Alcohol Dependence 207, pages 107798.
Crossref
Crossref
Nihit Kumar, Michael J Mancino, Jeff D Thostenson, Janette McGaugh & Alison H Oliveto. (2020) Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial. Substance Abuse: Research and Treatment 14, pages 117822182097092.
Crossref
Crossref
Ewa Galaj, Eddy D. Barrera & Robert Ranaldi. (2020) Therapeutic efficacy of environmental enrichment for substance use disorders. Pharmacology Biochemistry and Behavior 188, pages 172829.
Crossref
Crossref
Antonia M. Savarese & John C. Crabbe. 2020. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
687
698
.
Katrina M. Daigle, Nicole A. Heller, Ella J. Sulinski, Juyoung Shim, William Lindblad, Mark S. Brown, Julie A. Gosse & Marie J. Hayes. (2019) Maternal responsivity and oxytocin in opioid‐dependent mothers. Developmental Psychobiology 62:1, pages 21-35.
Crossref
Crossref
Marie Shigematsu-Locatelli, Takashi Kawano, Tsuyoshi Koyama, Hideki Iwata, Atsushi Nishigaki, Bun Aoyama, Hiroki Tateiwa, Noriko Kitaoka & Masataka Yokoyama. (2019) Therapeutic experience with tramadol for opioid dependence in a patient with chronic low back pain: a case report. JA Clinical Reports 5:1.
Crossref
Crossref
Joanne Neale, Charlotte N. E. Tompkins & John Strang. (2019) Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations. Harm Reduction Journal 16:1.
Crossref
Crossref
Joseph K. Nuamah, Farzan Sasangohar, Madhav Erraguntla & Ranjana K. Mehta. (2019) The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies. BMC Medical Informatics and Decision Making 19:1.
Crossref
Crossref
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman & Zheng-Xiong Xi. (2019) Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology 158, pages 107609.
Crossref
Crossref
Geoffrey Maina, Alexander Crizzle, Sithokozile Maposa & Bonnie Fournier. (2019) Sociodemographic Profiles and Clinical Outcomes for Clients on Methadone Maintenance Treatment in a Western Canadian Clinic: Implications for Practice. Journal of Forensic Nursing 15:4, pages 231-241.
Crossref
Crossref
Tyler S. Oesterle, Nuria J. Thusius, Teresa A. Rummans & Mark S. Gold. (2019) Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings 94:10, pages 2072-2086.
Crossref
Crossref
Charlotte N.E. Tompkins, Joanne Neale & John Strang. (2019) Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder. Journal of Substance Abuse Treatment 104, pages 64-71.
Crossref
Crossref
Robert W. Gould, Barak W. Gunter, Michael Bubser, Robert T. Matthews, Laura B. Teal, Madeline G. Ragland, Thomas M. Bridges, Aaron T. Garrison, Danny G. Winder, Craig W. Lindsley & Carrie K. Jones. (2019)
Acute Negative Allosteric Modulation of M
5
Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on Antinociception
. ACS Chemical Neuroscience 10:8, pages 3740-3750.
Crossref
Crossref
Biren Patel & Thomas R. Kosten. (2019) Keeping Up with Clinical Advances: Opioid Use Disorder. CNS Spectrums 24:S1, pages 14-24.
Crossref
Crossref
Cora Peterson, Likang Xu, Curtis Florence & Karin A. Mack. (2019) Opioid-related US hospital discharges by type, 1993–2016. Journal of Substance Abuse Treatment 103, pages 9-13.
Crossref
Crossref
Sean J. O’Sullivan, Evangelia Malahias, James Park, Ankita Srivastava, Beverly A. S. Reyes, Jon Gorky, Rajanikanth Vadigepalli, Elisabeth J. Van Bockstaele & James S. Schwaber. (2019) Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis. Frontiers in Neuroscience 13.
Crossref
Crossref
Joanne Neale, Charlotte N. E. Tompkins & John Strang. (2019) Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences. Drug and Alcohol Review 38:5, pages 510-518.
Crossref
Crossref
Dany Khalaf, Maryse Hayek, Jules-Joel Bakhos & Fadi Abou-Mrad. (2019) Comparative study between prison- and community-based treatment satisfaction for opioid use disorder in Lebanon. International Journal of Prisoner Health 15:2, pages 138-152.
Crossref
Crossref
Henk van Steenbergen, Marie Eikemo & Siri Leknes. (2019) The role of the opioid system in decision making and cognitive control: A review. Cognitive, Affective, & Behavioral Neuroscience 19:3, pages 435-458.
Crossref
Crossref
Samuel Obeng, Abdulmajeed Jali, Yi Zheng, Huiqun Wang, Kathryn L. Schwienteck, Chongguang Chen, David L. Stevens, Hamid I. Akbarali, William L. Dewey, Mathew L. Banks, Lee-Yuan Liu-Chen, Dana E. Selley & Yan Zhang. (2019) Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment. ACS Chemical Neuroscience 10:5, pages 2518-2532.
Crossref
Crossref
Xiaoqiang Wang, Yantao Liu, Xiaozhi Wu, Yan Zhang, RuiRui Pan, Weifeng Yu & Feixiang Wu. (2019) Engineered endomorphin-2 gene: A novel therapy for improving morphine reinstatement in CPP model of rats by using deficient adenovirus as the vector. Biochemical and Biophysical Research Communications 513:1, pages 141-146.
Crossref
Crossref
Yi Zheng, Samuel Obeng, Huiqun Wang, Abdulmajeed M. Jali, Bharath Peddibhotla, Dwight A. Williams, Chuanchun Zou, David L. Stevens, William L. Dewey, Hamid I. Akbarali, Dana E. Selley & Yan Zhang. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4′-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands. Journal of Medicinal Chemistry 62:2, pages 561-574.
Crossref
Crossref
David R. Maguire, Lisa R. Gerak, James H. Woods, Stephen M. Husbands, Alex Disney & Charles P. France. (2019) Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics 368:1, pages 88-99.
Crossref
Crossref
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, Matthew T. Eddy & Kurt Wüthrich. (2018) GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nature Reviews Drug Discovery 18:1, pages 59-82.
Crossref
Crossref
Melissa Henry, Ali Alias, Saul Frenkiel, Keith Richardson, Michael Hier, Anthony Zeitouni, Karen Kost, Alex Mlynarek, Martin Black, Christina MacDonald, Gabrielle Chartier & Zeev Rosberger. (2019) Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post-head and neck cancer diagnosis: A longitudinal study. Psycho-Oncology 28:1, pages 107-115.
Crossref
Crossref
Lisa Moran, Eamon Keenan & Khalifa Elmusharaf. (2018) Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland’s drug and alcohol services. BMC Health Services Research 18:1.
Crossref
Crossref
Joanne Neale, Charlotte N.E. Tompkins, Rebecca McDonald & John Strang. (2018) Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin. Drug and Alcohol Dependence 189, pages 1-7.
Crossref
Crossref
Taha Ahmad, Monica A. Valentovic & Gary O. Rankin. (2018) Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics. Biochemical Pharmacology 153, pages 196-204.
Crossref
Crossref
Nicolas J. Schlienz, Dustin C. Lee, Maxine L. Stitzer & Ryan Vandrey. (2018) The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug and Alcohol Dependence 187, pages 254-260.
Crossref
Crossref
Michael Z. Liao, Chunying Gao, Brian R. Phillips, Naveen K. Neradugomma, Lyrialle W. Han, Deepak Kumar Bhatt, Bhagwat Prasad, Danny D. Shen & Qingcheng Mao. (2018) Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation. Drug Metabolism and Disposition 46:2, pages 100-108.
Crossref
Crossref
Angélica Faleiros da Silva Maia, Leonardo da Silva Neto, Frederico Duarte Garcia, Rosemeire Brondi Alves & Ângelo de Fátima. 2018. Discovery and Development of Neuroprotective Agents from Natural Products. Discovery and Development of Neuroprotective Agents from Natural Products
415
434
.
Youssef Mahfoud & Michael Ignatowski. 2018. Suicide Prevention. Suicide Prevention
109
118
.
Alan K. Davis, Joseph P. Barsuglia, Austin-Marley Windham-Herman, Marta Lynch & Martin Polanco. (2017) Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. Journal of Psychedelic Studies 1:2, pages 65-73.
Crossref
Crossref
Kristi N Lorelli. (2017) Bioavailability Differences in Naltrexone: Oral and Injectable, Extended Release. MOJ Bioequivalence & Bioavailability 3:6.
Crossref
Crossref
Yener Unhelkar, Karen Murrell & Christopher Bryant. 2017. Big Book of Emergency Department Psychiatry. Big Book of Emergency Department Psychiatry
199
234
.
Cornel N. Stanciu, Oliver M. Glass & Thomas M. Penders. (2017) Use of Buprenorphine in treatment of refractory depression—A review of current literature. Asian Journal of Psychiatry 26, pages 94-98.
Crossref
Crossref
Julia Woo, Anuja Bhalerao, Monica Bawor, Meha Bhatt, Brittany Dennis, Natalia Mouravska, Laura Zielinski & Zainab Samaan. (2017) “Don’t Judge a Book by Its Cover”: A Qualitative Study of Methadone Patients’ Experiences of Stigma. Substance Abuse: Research and Treatment 11, pages 117822181668508.
Crossref
Crossref
Giordano de Guglielmo, Marsida Kallupi, Giulia Scuppa, Gregory Demopulos, George Gaitanaris & Roberto Ciccocioppo. (2016) Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents. Psychopharmacology 234:2, pages 223-234.
Crossref
Crossref
Yamikani Ndasauka, Zhengde Wei & Xiaochu Zhang. 2017. Substance and Non-substance Addiction. Substance and Non-substance Addiction
3
19
.
Christopher J. Hammond. (2016) The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders. Child and Adolescent Psychiatric Clinics of North America 25:4, pages 685-711.
Crossref
Crossref
Jemima A. Frimpong, Erick G. Guerrero, Yinfei Kong & Tina Kim. (2016) Abstinence at Successful Discharge in Publicly Funded Addiction Health Services. The Journal of Behavioral Health Services & Research 43:4, pages 661-675.
Crossref
Crossref
Georgi Vasilev, Svetla Milcheva & Jasmin Vassileva. (2016) Opioid Use in the Twenty First Century: Similarities and Differences Across National Borders. Current Treatment Options in Psychiatry 3:3, pages 293-305.
Crossref
Crossref
Jeremy Mayer, Timothy Mayer, Bonnie Stabile, Kathleen Kane-Willis, Scott Metzger, Katharine A. Neill & James Swartz. (2016) Medical System Rant and Response: Perspective of a Substance Abuse Counselor. World Medical & Health Policy 8:3, pages 344-353.
Crossref
Crossref
Ziva D. Cooper, Kirk W. Johnson, Martina Pavlicova, Andrew Glass, Suzanne K. Vosburg, Maria A. Sullivan, Jeanne M. Manubay, Diana M. Martinez, Jermaine D. Jones, Phillip A. Saccone & Sandra D. Comer. (2016) The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addiction Biology 21:4, pages 895-903.
Crossref
Crossref
Panos Zanos, Polymnia Georgiou, Loreto Rojo Gonzalez, Susanna Hourani, Ying Chen, Ian Kitchen, Brigitte L Kieffer, Raphaelle Winsky-Sommerer & Alexis Bailey. (2016)
Emotional Impairment and Persistent Upregulation of mGlu
5
Receptor following Morphine Abstinence: Implications of an mGlu
5
-MOPr Interaction
. International Journal of Neuropsychopharmacology 19:7, pages pyw011.
Crossref
Crossref
Kiri L. Wills & Linda A. Parker. (2016) Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature. Frontiers in Pharmacology 7.
Crossref
Crossref
Stacey C. Sigmon, Mollie E. Miller, Andrew C. Meyer, Kathryn Saulsgiver, Gary J. Badger, Sarah H. Heil & Stephen T. Higgins. (2016) Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial. Addiction 111:5, pages 903-912.
Crossref
Crossref
Idaira Oliva & Matthew J. Wanat. (2016) Ventral Tegmental Area Afferents and Drug-Dependent Behaviors. Frontiers in Psychiatry 7.
Crossref
Crossref
Tara Rezapour, Elise E. DeVito, Mehmet Sofuoglu & Hamed Ekhtiari. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions
345
369
.
B. Andraka-Christou. 2016. Animal Models for Medications Screening to Treat Addiction. Animal Models for Medications Screening to Treat Addiction
15
38
.
M.T. Bobes-Bascarán, M.T. Bascarán, S. Al-Halabí, P.A. Saiz, M. Bousoño, M.P. García-Portilla & J. Bobes. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
595
602
.
Daryl Shorter, John Hsieh & Thomas R. Kosten. (2015) Pharmacologic management of comorbid post-traumatic stress disorder and addictions. The American Journal on Addictions 24:8, pages 705-712.
Crossref
Crossref
Stacey C. Sigmon, Andrew C. Meyer, Bryce Hruska, Taylor Ochalek, Gail Rose, Gary J. Badger, John R. Brooklyn, Sarah H. Heil, Stephen T. Higgins, Brent A. Moore & Robert P. Schwartz. (2015) Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility. Addictive Behaviors 51, pages 136-142.
Crossref
Crossref
Marjorie Meyer & Julie Phillips. (2015) Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas. Preventive Medicine 80, pages 18-22.
Crossref
Crossref
Stacey C. Sigmon. (2015) Interim treatment: Bridging delays to opioid treatment access. Preventive Medicine 80, pages 32-36.
Crossref
Crossref
Anna Ratzliff, Jürgen Unutzer, Wayne Katon & Kari A StephensSusan E. Collins, Mark H. Duncan, Andrew J. Saxon, Joseph O. Merrill & Richard K. Ries. 2015. Integrated Care. Integrated Care
124
152
.
Megan Laudenbach, Federico Baruffaldi, Jeffrey S. Vervacke, Mark D. Distefano, Philip J. Titcombe, Daniel L. Mueller, Noah J. Tubo, Thomas S. Griffith & Marco Pravetoni. (2015) The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse. The Journal of Immunology 194:12, pages 5926-5936.
Crossref
Crossref
Edward V. Nunes, Evgeny Krupitsky, Walter Ling, Jacqueline Zummo, Asli Memisoglu, Bernard L. Silverman & David R. Gastfriend. (2015) Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX). Journal of Addiction Medicine 9:3, pages 238-243.
Crossref
Crossref
Christine Timko, Maureen Below, Nicole R. Schultz, Deborah Brief & Michael A. Cucciare. (2015) Patient and Program Factors that Bridge the Detoxification-Treatment Gap: A Structured Evidence Review. Journal of Substance Abuse Treatment 52, pages 31-39.
Crossref
Crossref
Jennifer M. Fenn, Jennifer S. Laurent & Stacey C. Sigmon. (2015) Increases in Body Mass Index Following Initiation of Methadone Treatment. Journal of Substance Abuse Treatment 51, pages 59-63.
Crossref
Crossref
Leslie H. Lundahl & Mark K. Greenwald. (2015) Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. Drug and Alcohol Dependence 149, pages 187-193.
Crossref
Crossref
Yunyun Yuan, Saheem A. Zaidi, David L. Stevens, Krista L. Scoggins, Philip D. Mosier, Glen E. Kellogg, William L. Dewey, Dana E. Selley & Yan Zhang. (2015) Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligands. Bioorganic & Medicinal Chemistry 23:8, pages 1701-1715.
Crossref
Crossref
Thomas F. Northrup, Angela L. Stotts, Charles Green, Jennifer S. Potter, Elise N. Marino, Robrina Walker, Roger D. Weiss & Madhukar Trivedi. (2015) Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: A discrete survival and growth mixture model. Addictive Behaviors 41, pages 20-28.
Crossref
Crossref
Traci R. Rieckmann, Amanda J. Abraham, Anne E. Kovas, Bentson H. McFarland & Paul M. Roman. (2014) Impact of research network participation on the adoption of buprenorphine for substance abuse treatment. Addictive Behaviors 39:5, pages 889-896.
Crossref
Crossref
Jeffrey M. Witkin, Michael A. Statnick, Linda M. Rorick-Kehn, John E. Pintar, Michael Ansonoff, Yanyun Chen, R. Craig Tucker & Roberto Ciccocioppo. (2014) The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacology & Therapeutics 141:3, pages 283-299.
Crossref
Crossref
J.J. Taylor, M. Laudenbach, A.M. Tucker, M.K. Jenkins & M. Pravetoni. (2014) Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse. Journal of Immunological Methods 405, pages 74-86.
Crossref
Crossref
Diane E. Arnold-Reed, Tom Brett, Lakkhina Troeung, Jasmine O'Neill, Rupert Backhouse & Max K. Bulsara. (2014) Multimorbidity in Patients Enrolled in a Community-Based Methadone Maintenance Treatment Programme Delivered through Primary Care. Journal of Comorbidity 4:1, pages 46-54.
Crossref
Crossref
Amy Baker Dennis & Tamara Pryor. 2014. Eating Disorders, Addictions and Substance Use Disorders. Eating Disorders, Addictions and Substance Use Disorders
227
266
.
Rizwana Quraishi, Raka Jain & Anish P. Kakkolil. (2013) Naltrexone Level and Biochemical Profile of Opiate-dependent Patients on Naltrexone Maintenance Program. Addictive Disorders & Their Treatment 12:4, pages 231-235.
Crossref
Crossref
Thomas A. Nguyen, Jennie H. Hahn & Stephen M. Strakowski. (2013) Pharmacotherapies for treating opioid use disorder. CNS Spectrums 18:6, pages 289-295.
Crossref
Crossref
Jamie Peters, Tommy Pattij & Taco J. De Vries. (2013) Targeting cocaine versus heroin memories: divergent roles within ventromedial prefrontal cortex. Trends in Pharmacological Sciences 34:12, pages 689-695.
Crossref
Crossref
Yunyun Yuan, Saheem A. Zaidi, Orgil Elbegdorj, Lindsey C. K. Aschenbach, Guo Li, David L. Stevens, Krista L. Scoggins, William L. Dewey, Dana E. Selley & Yan Zhang. (2013) Design, Synthesis, and Biological Evaluation of 14-Heteroaromatic-Substituted Naltrexone Derivatives: Pharmacological Profile Switch from Mu Opioid Receptor Selectivity to Mu/Kappa Opioid Receptor Dual Selectivity. Journal of Medicinal Chemistry 56:22, pages 9156-9169.
Crossref
Crossref
Evgeny Krupitsky, Edwin Zvartau, Elena Blokhina, Elena Verbitskaya, Marina Tsoy, Valentina Wahlgren, Andrey Burakov, Dimitry Masalov, Tatyana N. Romanova, Vladimir Palatkin, Arina Tyurina, Tatyana Yaroslavtseva, Rajita Sinha & Thomas R. Kosten. (2013) Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug and Alcohol Dependence 132:3, pages 674-680.
Crossref
Crossref
Cassie L. Boggs, Mary G. Ripple, Zabiullah Ali, Melissa Brassell, Barry Levine, Rebecca Jufer‐Phipps, Suzanne Doyon & David R. Fowler. (2013) Anaphylaxis After the Injection of Buprenorphine. Journal of Forensic Sciences 58:5, pages 1381-1383.
Crossref
Crossref
Alison Oliveto, Michael Mancino, Nichole Sanders, Christopher Cargile, J. Benjamin Guise, Warren Bickel & W. Brooks Gentry. (2013) Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. European Journal of Pharmacology 715:1-3, pages 424-435.
Crossref
Crossref
David J. Nutt, Leslie A. King & David E. Nichols. (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews Neuroscience 14:8, pages 577-585.
Crossref
Crossref
Therese A. Kosten, Xiaoyun Y. Shen, Patrick W. O'Malley, Berma M. Kinsey, Ernest D. Lykissa, Frank M. Orson & Thomas R. Kosten. (2013) A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 45, pages 223-229.
Crossref
Crossref
P. Garrido, A. Prat, I. Crespo, C. Lopez-Ortíz, D. Lumbreras, V. Bertran, S. Gomez & J.J. Abades. (2013) Avances en el desarrollo de vacunas frente a sustancias adictivas (ii). Vacunas antiopiáceos. Otras vacunas. Vacunas 14:3, pages 120-129.
Crossref
Crossref
Ryan Vandrey, Maxine L. Stitzer, Miriam Z. Mintzer, Marilyn A. Huestis, Jeannie A. Murray & Dayong Lee. (2013) The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence 128:1-2, pages 64-70.
Crossref
Crossref
Stéphane Allouche, Thierry Le Marec, Florence Noble & Nicolas Marie. (2013) Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 40, pages 286-291.
Crossref
Crossref
Jennifer Prah Ruger, Marek Chawarski, Mahmud Mazlan, Nora Ng & Richard Schottenfeld. (2012) Cost-Effectiveness of Buprenorphine and Naltrexone Treatments for Heroin Dependence in Malaysia. PLoS ONE 7:12, pages e50673.
Crossref
Crossref
Yi Deng, Qian Bu, Zhengtao Hu, Pengchi Deng, Guangyan Yan, Jiachuan Duan, Chunyan Hu, Jiaqing Zhou, Xue Shao, Jinxuan Zhao, Yan Li, Ruiming Zhu, Yinglan Zhao & Xiaobo Cen. (2012) 1H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention. Journal of Neuroscience Research 90:11, pages 2154-2162.
Crossref
Crossref
Angela L. Stotts, Charles Green, Akihiko Masuda, John Grabowski, Kelly Wilson, Thomas F. Northrup, F. Gerard Moeller & Joy M. Schmitz. (2012) A Stage I pilot study of acceptance and commitment therapy for methadone detoxification. Drug and Alcohol Dependence 125:3, pages 215-222.
Crossref
Crossref
Robert K. Vinson. (2012) Pharmacokinetics of a New Immediate-Release Methadone Tablet Formulation with Decreased In vitro Solubility. Clinical Drug Investigation 32:7, pages 487-495.
Crossref
Crossref
Antonio DʼAmore, Filomena Romano, Vincenzo Biancolillo, Guglielmo Lauro, Ciro Armenante, Anna Pizzirusso, Salvatore Del Tufo, Ciro Ruoppolo, Francesco Auriemma, Francesco Cassese, Patrizia Oliva & Patrizia Amato. (2012) Evaluation of Buprenorphine Dosage Adequacy in Opioid Receptor Agonist Substitution Therapy for Heroin Dependence. Clinical Drug Investigation 32:7, pages 427-432.
Crossref
Crossref
Zhengtao Hu, Yi Deng, Chunyan Hu, Pengchi Deng, Qian Bu, Guangyan Yan, Jiaqing Zhou, Xue Shao, Jinxuan Zhao, Yan Li, Ruiming Zhu, Youzhi Xu, Yinglan Zhao & Xiaobo Cen. (2012) 1H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention. Behavioural Brain Research 231:1, pages 11-19.
Crossref
Crossref
M. Pravetoni, M. Le Naour, T. M. Harmon, A. M. Tucker, P. S. Portoghese & P. R. Pentel. (2012) An Oxycodone Conjugate Vaccine Elicits Drug-Specific Antibodies that Reduce Oxycodone Distribution to Brain and Hot-Plate Analgesia. Journal of Pharmacology and Experimental Therapeutics 341:1, pages 225-232.
Crossref
Crossref
Bonnie A. Jackson, Mary Sueltenfuss & Christopher V. Maani. (2012) Hope for Recovering Burn Patients—The Multidisciplinary Approach (Ultrarapid Opioid Detoxification Under Anesthesia). Perioperative Nursing Clinics 7:1, pages 77-81.
Crossref
Crossref
Qian Bu, Yanzhu Yang, Guangyan Yan, Zhengtao Hu, Chunyan Hu, Jiachuan Duan, Lei Lv, Jiaqing Zhou, Jinxuan Zhao, Xue Shao, Yi Deng, Yan Li, Hongyu Li, Ruiming Zhu, Yinglan Zhao & Xiaobo Cen. (2012) Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. Journal of Proteomics 75:4, pages 1330-1342.
Crossref
Crossref
X Y Shen, F M Orson & T R Kosten. (2011) Vaccines Against Drug Abuse. Clinical Pharmacology & Therapeutics 91:1, pages 60-70.
Crossref
Crossref
Rie Yamamoto, Shinri Takasuga, Yoshimasa Yoshida, Shoichi Mafune, Katsuya Kominami, Chiyo Sutoh, Yukihiro Kato, Mitsugu Yamauchi, Masao Ito, Kiyoshi Kanamura & Mine Kinoshita. (2012) In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. International Journal of Pharmaceutics 422:1-2, pages 132-138.
Crossref
Crossref
Mark L. Kraus, Daniel P. Alford, Margaret M. Kotz, Petros Levounis, Todd W. Mandell, Marjorie Meyer, Edwin A. Salsitz, Norman Wetterau & Stephen A. Wyatt. (2011) Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction. Journal of Addiction Medicine 5:4, pages 254-263.
Crossref
Crossref
Andrea DiMartini, Catherine Crone & Mary Amanda Dew. (2011) Alcohol and Substance Use in Liver Transplant Patients. Clinics in Liver Disease 15:4, pages 727-751.
Crossref
Crossref
Christopher V. Maani, Peter A. DeSocio, Richard K. Jansen, Jason D. Merrell, Laura L. McGhee, Alan Young, James F. Williams, Katie Tyrell, Bonnie A. Jackson, Maria L. Serio-Melvin, Lorne H. Blackbourne & Evan M. Renz. (2011) Use of Ultra Rapid Opioid Detoxification in the Treatment of US Military Burn Casualties. Journal of Trauma: Injury, Infection & Critical Care 71:1, pages S114-S119.
Crossref
Crossref
Sergio Perez-Alvarez, Victoria Iglesias-Guimarais, María E. Solesio, Raquel María Melero-Fernandez de Mera, Víctor J. Yuste, María F. Galindo & Joaquín Jordán. (2011) Methadone induces CAD degradation and AIF-mediated necrotic-like cell death in neuroblastoma cells. Pharmacological Research 63:4, pages 352-360.
Crossref
Crossref
Gabriel Kaplan & Iliyan Ivanov. (2011) Pharmacotherapy for Substance Abuse Disorders in Adolescence. Pediatric Clinics of North America 58:1, pages 243-258.
Crossref
Crossref
Mark A. Ilgen, Elizabeth Haas, Ewa Czyz, Linda Webster, John T. Sorrell & Stephen Chermack. (2011) Treating Chronic Pain in Veterans Presenting to an Addictions Treatment Program. Cognitive and Behavioral Practice 18:1, pages 149-160.
Crossref
Crossref
Kimberly L. KjomeF. Gerard Moeller. (2011) Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence. Substance Abuse: Research and Treatment 5, pages SART.S5452.
Crossref
Crossref
Anne Lingford-Hughes, Ben Watson, Nicola Kalk & Alastair Reid. (2010) Neuropharmacology of addiction and how it informs treatment. British Medical Bulletin 96:1, pages 93-110.
Crossref
Crossref
Barbara Teresa Andraka-Christou. (2016) Essay: Improving Drug Courts Through Medication-Assisted Treatment for Addiction. SSRN Electronic Journal.
Crossref
Crossref